7.03
0.02 (0.29%)
0.02 (0.29%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,248,458 |
|
|||||
| News | - | ||||||
| Day High | 7.10 | Low High |
|||||
| Day Low | 6.865 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.02 | 0.29% | 7.03 | 00:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.99 | 6.865 | 7.10 | 7.06 | 7.01 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,168 | 1,248,458 | $ 7.00 | $ 8,738,437 | - | 4.81 - 8.645 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:48:18 | 1 | $ 6.81 | USD |
Period:
Draw Mode:
Catalyst Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 722.54M | 102.78M | 95.03M | $ 140.83M | $ 41.25M | 0.37 | 16.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -20.00k | 9.50% |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.74 | 7.225 | 6.425 | 6.82 | 1,528,687 | 0.29 | 4.3% |
| 1 Month | 7.08 | 7.47 | 6.15 | 6.70 | 1,186,516 | -0.05 | -0.71% |
| 3 Months | 8.25 | 8.64 | 6.15 | 7.13 | 1,159,805 | -1.22 | -14.79% |
| 6 Months | 6.83 | 8.645 | 5.24 | 7.20 | 1,154,620 | 0.20 | 2.93% |
| 1 Year | 5.71 | 8.645 | 4.81 | 6.71 | 1,025,100 | 1.32 | 23.12% |
| 3 Years | 3.88 | 8.645 | 2.55 | 4.88 | 1,585,168 | 3.15 | 81.19% |
| 5 Years | 2.76 | 8.645 | 1.85 | 4.36 | 1,453,021 | 4.27 | 154.71% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. |